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Reconstruction of diaminopimelic 
acid biosynthesis allows 
characterisation of Mycobacterium 
tuberculosis N-succinyl-L,L-
diaminopimelic acid desuccinylase
Veeraraghavan Usha1,*, Adrian J. Lloyd2,*, David I. Roper2, Christopher G. Dowson2, 
Guennadi Kozlov3, Kalle Gehring3, Smita Chauhan2, Hasan T. Imam4, Claudia A. Blindauer4 & 
Gurdyal S. Besra1
With the increased incidence of tuberculosis (TB) caused by Mycobacterium tuberculosis there is an 
urgent need for new and better anti-tubercular drugs. N-succinyl-L,L-diaminopimelic acid desuccinylase 
(DapE) is a key enzyme in the succinylase pathway for the biosynthesis of meso-diaminopimelic acid 
(meso-DAP) and L-lysine. DapE is a zinc containing metallohydrolase which hydrolyses N-succinyl L,L 
diaminopimelic acid (L,L-NSDAP) to L,L-diaminopimelic acid (L,L-DAP) and succinate. M. tuberculosis 
DapE (MtDapE) was cloned, over-expressed and purified as an N-terminal hexahistidine ((His)6) tagged 
fusion containing one zinc ion per DapE monomer. We redesigned the DAP synthetic pathway to 
generate L,L-NSDAP and other L,L-NSDAP derivatives and have characterised MtDapE with these 
substrates. In contrast to its other Gram negative homologues, the MtDapE was insensitive to inhibition 
by L-captopril which we show is consistent with novel mycobacterial alterations in the binding site of 
this drug.
TB is a major cause of mortality. In 2011, there were 12 million cases of TB of which an estimated 1.4 million were 
fatal1. The spread of multi, extremely and totally drug resistant TB has necessitated the identification and charac-
terisation of new drug targets to treat TB2.
The DAP biosynthetic pathway operates only in bacteria and plants. It synthesises meso-DAP (or D,L-DAP), 
the precursor of L-lysine3,4. M. tuberculosis incorporates DAP into the stem peptide of its peptidoglycan5,6. 
Therefore, meso-DAP synthesis is an attractive antimicrobial target because it targets both peptidoglycan and 
protein synthesis. Hence, a DapE inhibitor would neither be toxic or undermined by the presence of any exoge-
nous source of the diamino acid in the human host7.
There are three pathways of DAP synthesis3,4,7 and all three involve synthesis of L-2,3,4,5-tetrahydrodipicolinic 
acid (L-THDP). In the succinylase pathway, L-THDP is acylated usually with succinyl-CoA by DapD 
(acyl-CoA:THDP N-acyl transferase), to form N-succinyl-2-amino-6-ketopimelic acid (NS-AKP), which is 
transaminated with L-glutamate by DapC (N-acyl-DAP aminotransferase) or its homologue ArgD (acetylorni-
thine/succinyl DAP aminotransferase) to furnish L,L-NSDAP. This is hydrolysed to succinate and L,L-DAP by 
DapE (E.C. 3.5.1.18) which in M. tuberculosis (MtDapE) is encoded by dapE (Rv1202). L,L-DAP is epimerized to 
meso-DAP by DAP epimerase (DapF). In the dehydrogenase pathway, L-THDP is directly reduced to meso-DAP 
by NADP+-linked meso-DAP dehydrogenase3,4,7. The acetylase pathway consists of three reaction steps prior to 
formation of L,L-DAP which is converted to meso-DAP by DapF8.
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DapE typically possesses two catalytic metal binding sites9,10: one of high affinity which is essential and is 
always occupied by zinc and the other of low affinity which is not essential for catalysis and loses metal upon 
extensive dialysis11,12. Evidence of a dinuclear zinc active site in the Haemophilus influenza DapE (HiDapE) and 
the Neisseria meningitidis DapE (NmDapE) was obtained via extended X-ray absorption fine spectra (EXAFS)13 
and X-ray crystallography9,10. The presence of zinc in the active site of DapE has been exploited as a target for 
thiol-containing inhibitors, such as L-captopril10,14,15.
The crystal structures of both mono and dinuclear zinc forms of HiDapE have been solved9. MtDapE has also 
recently been crystallised16. Inspection of the sequence of the structurally characterised HiDapE and that of other 
DapE sequences reveals strict conservation of all metal ligand and substrate binding residues12,17. Two highly 
conserved histidines that are present in the active site act as zinc ligands12,17.
Deletion of the gene encoding DapE is lethal to Helicobacter pylori and M.smegmatis18,19 but can be comple-
mented by DAP-supplementation18. Consequently there has been interest in this protein as a potential antimicro-
bial target14. However, an impediment to the facile characterization of DapE, and its exploitation as a drug target is 
the unavailability of its substrate. Therefore we devised a method to synthesise L,L-NSDAP and analogues thereof 
using a novel in vitro pathway constructed from the two natural DAP synthetic pathways (Fig. 1a). To achieve 
this, we over-expressed and purified MtDapE, Corynebacterium glutamicum DAP dehydrogenase (Cgmeso-DAP 
dehydrogenase), Bacillus anthracis DapF (BaDapF), Escherichia coli ArgD (EcArgD) and E. coli DapD (EcDapD).
Results & Discussion
Overexpression and purification of MtDapE, Cgmeso-DAP dehydrogenase, BaDapF, EcArgD 
and EcDapD. MtDapE was obtained in the soluble fraction which was purified by a single step Ni2+ 
Sepharose affinity chromatography. The purified MtDapE fractions were electrophoretically homogeneous 
(Supplementary Fig. S1a). The final yield was 2–3 mg of pure MtDapE per litre of culture. Activity of purified 
recombinant MtDapE was stable at − 80 °C for about 3 weeks. Cgmeso-DAP dehydrogenase and BaDapF were 
Figure 1. Synthesis and detection of L,L-NSDAP. (a) Synthesis: meso-DAP is oxidised with NADP+ to L-
THDP by Cgmeso-DAP dehydrogenase, yielding an increase in absorbance at 340 nm. L-THDP is succinylated 
with succinyl-CoA (or acylated by an alternative acyl-CoA) by EcDapD to yield NS-AKP which is amidated 
with glutamate to form L,L-NSDAP or its acyl derivative by EcArgD. Reaction condition 1 (see text) is 
performed in this way. Reaction condition 2 (see text) recycles the NADPH and ammonia produced by 
Cgmeso-DAP dehydrogenase with glutamate dehydrogenase (green broken line). (b) Detection: L,L-NSDAP 
is cleaved by MtDapE to succinate and L,L-DAP which is epimerised by BaDapF and reduced by Cgmeso-DAP 
dehydrogenase with a concomitant increase in absorbance at 340 nm.
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similarly purified to electrophoretic homogeneity as judged by SDS-PAGE (Supplementary Fig. S1b and S1c). 
EcArgD and EcDapD were also purified to apparent homogeneity (Supplementary Fig. S1d and S1e) and yields of 
about 10 mg of EcArgD and 15 mg of EcDapD were obtained per litre of culture.
Metal content and dependence of MtDapE. DapE homologues from other organisms require a tightly 
bound zinc ion for catalysis9–13. To determine whether MtDapE was similar in this regard, we removed zinc from 
pure MtDapE by dialysis against EDTA and 1, 10-phenanthroline. This resulted in complete loss of MtDapE 
activity. We then analysed the untreated and metal chelator treated MtDapE by inductively coupled plasma opti-
cal emission spectroscopy (Methods section). The treated enzyme contained no detectable Zn2+. In contrast, 
untreated MtDapE contained 0.8 ± 0.1 Zn2+ per monomer and was enzymatically active.
DapE proteins when fully substituted contain two zinc/monomer9,10,20. However, there is little difference 
in catalysis incurred on the loss of a single zinc atom from the active site10–12,15. This has led to postulation of 
a catalytic mechanism, wherein histidine 349 of HiDapE (H330 in MtDapE) takes on the role of the second 
zinc ion in correctly orientating L,L-NSDAP within the active site9. Our observation of the activity of a singly 
zinc-substituted MtDapE is consistent with the operation of a similar His-dependent mechanism in this myco-
bacterial enzyme.
Spectrophotometric assay for an enzymatic synthesis of L,L-NSDAP, L,L-NGDAP and other 
DAP derivatives. In order to characterise MtDapE, it was necessary to devise a convenient method for the 
synthesis of its substrate. We anticipated we could reverse the DAP dehydrogenase step, generating L-THDP from 
meso-DAP and NADP+ with E. coli DapD, succinyl-CoA (or other acyl-CoAs), E. coli DapC or its orthologue E. 
coli ArgD and glutamate, which would generate L,L-NSDAP, or acyl analogues thereof (Fig. 1a). Furthermore, 
we reasoned that we could follow this process by the addition of MtDapE and BaDapF allowing regeneration of 
meso-DAP which could be detected by the Cgmeso-DAP dehydrogenase originally present for the initial forma-
tion of L-THDP (Fig. 1b).
In these initial spectrophotometric experiments, we maintained the succinyl-CoA substrate of EcDapD at a 
concentration equal to that of meso-DAP to ensure a single turnover of the DAP added (detailed Fig. 2 legend). 
We were then able to monitor the synthesis of L,L-NSDAP as a function of NADPH synthesis with a concomitant 
increase in absorbance at 340 nm (Fig. 2a).
Consistent with this pathway, a jump in absorbance at 340 nm occurred on the addition of meso-DAP con-
sistent with the complete oxidation of the latter. No further increase in absorbance was detected on addition of 
EcDapD or EcArgD until BaDapF was added when there was an additional increase in absorbance equal to that 
on the addition of meso-DAP (Fig. 2a). This second increase in absorbance was dependent on EcArgD, EcDapD, 
BaDapF, succinyl-CoA and meso-DAP and was consistent with the formation of L,L-NSDAP and its consumption 
by DapE.
To test the flexibility of this system with respect to generation of acyl-L,L-DAP analogues of L,L-NSDAP, 
we repeated the above pathway reconstruction assays replacing succinyl-CoA with glutaryl, malonyl, butyryl, 
acetoacetyl, acetyl, and propionyl-CoA thiol esters (Fig. 2b–g). Glutaryl-CoA supported synthesis of a MtDapE 
active substrate almost as efficiently as succinyl-CoA (Fig. 2b). Far smaller or negligible quantities of product were 
generated with the other acyl-CoA thiol esters within the time frame of the experiment (Fig. 2c–g).
We therefore tested the possibility that malonyl, butyryl, acetoacetyl, acetyl or propionyl-CoA thiol esters 
could not support the EcDapD activity efficiently enough to generate detectable quantities of acyl-L,L-DAP ana-
logues over duration of the assay. Therefore, we assayed EcDapD and L-THDP dependent acyl-CoA deacylation 
via reduction of 5,5′ dithiobis(2-nitrobenzoic acid) by CoA thiol to para-thionitrobenzoate at 412 nm21 (Methods 
section; Supplementary Fig. S2a,S2b).
EcDapD assays showed that the best acyl-CoA substrate was succinyl-CoA (100%), followed by glutaryl-CoA 
(4.4%), acetoacetyl-CoA (0.042%), acetyl-CoA (0.042%), malonyl-CoA (0.022%) and butyryl-CoA (0.0018%). 
No EcDapD activity was supported by propionyl-CoA over the duration of the assay. The data suggested that 
insignificant generation of these acyl-L,L-DAP products may well be a consequence of the substrate specificity 
of EcDapD.
These results were consistent with the crystal structure of the MtDapD: succinyl-CoA complex where a cor-
rectly sited carboxyl of the succinyl-CoA substrate is required to form electrostatic and hydrogen bonding inter-
actions with MtDapD21.
Enzymatic synthesis, purification and characterisation of L,L-NSDAP, L,L-NGDAP and other 
DAP derivatives. To synthesise MtDapE substrates preparatively, we reconfigured the spectrophotometric 
assay of L,L-acyl-DAP synthesis as a single pot method using EcArgD, EcDapD and Cgmeso-DAP dehydrogenase 
(Methods section; Fig. 1a, reaction condition 1). Additionally, in an alternate reaction scheme (Fig. 1a, green 
dotted line) NADPH generated by Cgmeso-DAP dehydrogenase could be continuously reconverted to the start-
ing NADP+ by L-glutamate dehydrogenase which consumed the 2-oxoglutarate generated by EcArgD and the 
NADPH and ammonia generated by Cgmeso-DAP dehydrogenase (Methods section; reaction condition 2). This 
reduced the amount of nicotinamide cofactor used in the synthesis, making purification of the desired products 
easier. Similar strategies have been employed for synthesis of peptidoglycan precursors22.
We recovered 4.42 μmols or 3.47 μmols L,L-NSDAP in 27.6 and 21.6% overall yield from reaction conditions 
1 and 2, respectively. The identity of L,L-NSDAP was confirmed by negative ion nanospray-MS analysis where 
the respective expected and observed values for the singly charged L,L-NSDAP [M-H]− ion were 289.1036; and 
289.1399 m/z (Fig. 3a). As confirmed by TLC, L,L-NSDAP obtained from reaction condition 1 was highly pure 
(Fig. 3c). No degradation of L,L-NSDAP was observed even after two years of storage at − 80 °C.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:23191 | DOI: 10.1038/srep23191
The ability to generate the MtDapE substrate lent itself to the synthesis of a number of acyl-analogues of 
L,L-NSDAP that we could use to probe the substrate specificity of MtDapE. We therefore pursued the synthesis 
of a number of L,L-acyl-DAP derivatives by varying the coenzyme A acyl donor utilised by DapD. However, 
cognisant of the negligible yields of acyl-L,L-DAP species afforded by most of the acyl-CoA species utilised in 
Fig. 2, we extended the incubation time to overnight to maximise the possibility of synthesising products from 
even the acyl-CoA donors that were least reactive in the spectrophotometric assay of enzymatic synthesis of 
N-L,L-acyl-DAP derivatives (Fig. 2d,f).
Following purification of the products of the attempted syntheses of the various N-L,L-acyl-DAP deriva-
tives, using DapE assays to follow elution of N-L,L-acyl-DAP species, we were able to confirm the synthesis of 
L,L-N-glutaryl-DAP (L,L-NG-DAP) enzymatically in 30.1% yield. TLC analysis of this species suggested it was 
essentially homogeneous (Fig. 3c). Negative ion nanospray-MS analysis (Fig. 3b) where the respective expected 
and observed m/z values for the singly charged L,L-NGDAP [M-H]− ion were 303.1192 and 303.1275 m/z con-
firmed the synthesis of this species.
Synthesis of L,L-N-malonyl, butyryl, acetoacetyl, acetyl and propionyl–DAP. Using absorbance 
at 215 nm to follow purification of N-L,L-acyl-DAP species (Methods section), we purified the products aris-
ing from syntheses designed to generate malonyl, acetoacetyl and butyryl-L,L-DAP. Negative ion nanospray-MS 
analysis indicated that although these compounds had been synthesised, they were characterised by very low 
ion intensities compared to contaminating ions in the corresponding mass spectra. Here, the expected/observed 
m/z values for L,L-N-malonyl-DAP and L,L-N-butyryl-DAP, respectively, were [M-H]−: 259.12939/259.0853 
and 275.08792/275.08546; and for [M+ Na-H]− were 281.1113/281.1131 and 297.0546/297.0120, respec-
tively. The corresponding expected/observed m/z value expected for L,L-N-acetoacetyl-DAP [M+ Na-H]− was 
295.096/295.1061. No ions could be detected confirming the synthesis of acetyl- or propionyl-L,L-DAP.
Figure 2. Spectrophotometric assay of the enzymatic synthesis of N-acyl L,L DAP. All assays contained 
20 mMTricine buffer pH 8.0, 10 mM MgCl2, 10 mM NADP+, 1.99 μM Cgmeso-DAP dehydrogenase, 8.03 μM 
DapD, 10 mM L-glutamate, 8.97 μM EcArgD, 2 mM PLP and 20 mM DTT at 0 time. The identity of the acyl 
group of the CoA thiol ester substrate is as indicated. (a) Succinyl-CoA: At 1, 0.1 mM meso-DAP was added. 
Once reduction of meso-DAP to L-THDP was complete, 0.1 mM succinyl CoA and 0.134 μM MtDapE was 
added at 2. Finally, 22.8 μM BaDapF was added at 3; (b) Glutaryl-CoA, (c) Malonyl-CoA, (d) Butyryl-CoA,  
(e) Acetoacetyl-CoA, (f) Acetyl-CoA and (g) Propionyl-CoA: Included in addition to the components present 
at 0 time in Panel 2(a) was 0.1 mM acyl-CoA as specified and 0.134 μM MtDapE. The absorbance at 340 nm was 
monitored at 37 °C. At 1, 0.1 mM meso-DAP was added. At 4, 22.8 μM BaDapF was added.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:23191 | DOI: 10.1038/srep23191
Apart from L,L-NSDAP and L,L-NGDAP, of the acyl-DAP species whose synthesis could be confirmed by 
mass spectrometry, only the synthesis designed to generate acetoacetyl-L,L-DAP produced sufficient mate-
rial to quantitate gravimetrically (5.56 μmols, equating to an overall yield of 22.2%). However, here, the lack of 
purity of the acetoacetyl-L,L-DAP product suggested by its mass spectral analysis indicated the true yield of this 
DAP-derivative was considerably less than that suggested by weight. Clearly, the current methodology did not 
lend itself to the generation of significant quantities of the remaining acyl-L,L-DAP species whose synthesis was 
attempted. This was in large part due to the restrictive substrate specificity of EcDapD.
Although synthesis of the L,L-N-malonyl, butyryl, acetoacetyl, acetyl and pyopionyl–DAP species was 
attempted, the yields were low enough to preclude their characterization as DapE substrates. Therefore, as a 
preparative technique our enzymatic approach lacked the flexibility of chemical syntheses that have generated 
L,L-N-acetyl-DAP, L,L-N-butyryl-DAP, and L,L-NGDAP23,24. It does however suggest that this method could 
generate possibly larger analogues of L,L-NSDAP such as L,L-NG-DAP and L,L-N-pimeloyl-DAP, as well as 
a range of NMR-active or radio labelled L,L-NSDAP species in laboratories unequipped for stereo-chemically 
controlled organic synthesis required to access DAP analogues4.
Kinetic characterisation of MtDapE. Having achieved a viable synthesis of L,L-NSDAP, we then kinet-
ically characterised MtDapE where its production of L,L-DAP from L,L-NSDAP could be monitored at 340 nm 
by coupling the enzyme to BaDapF and Cgmeso-DAP dehydrogenase catalysed reduction of NADP+ (Methods 
section). L,L-DAP production was dependent upon MtDapE and L,L-NSDAP (Fig. 4). Progress curves (Fig. 4a) 
of MtDapE showed a steady state preceded by a short lag of 10 to 20 seconds. The end point of the assay indicated 
almost complete consumption of the L,L-NSDAP in the assay. The relationship between DapE concentration and 
rate was strictly linear (Fig. 4b), indicating the assay quantitatively reported DapE activity.
The dependence of MtDapE activity on L,L-NSDAP concentration was hyperbolic and could be fitted to 
the Michaelis Menten equation (Fig. 4d) where the MtDapE Km, kcat and kcat/Km ratio for L,L-NSDAP were 
31.09 ± 3.71 μM, 4.85 ± 0.15 s−1 and 0.156μM.s respectively. This latter value is similar to that of E. coli DapE 
enzyme25 suggesting that these DapE homologues had similar catalytic efficiencies.
The temperature and pH optima for DapE catalysis were determined. The temperature optimum of the reac-
tion at pH 8.0 was between 37 to 42 °C (Supplementary Fig. S3a). The relationship between MtDapE activity and 
pH was bell-shaped with a pH optimum of 7.5 (Supplementary Fig. S3b). To ensure that this reflected MtDapE 
activity, the experiment was repeated at four-fold higher Cgmeso-DAP dehydrogenase or BaDapF concentrations 
(7.96 μM and 91.2 μM respectively), with similar results (Supplementary Fig. S3c and S3d). This suggested that the 
pH profile in Supplementary Fig. S3b reported the impact of pH on MtDapE activity.
The pH profile of MtDapE resembled that of HiDapE12. The half maximal values of the ascending limb of 
the pH profile for MtDapE was 6.7 (Supplementary Fig. S3b). This value could represent dissociation of the 
zinc-activated water molecule central to the DapE mechanism12 or the dissociation of H352 in MtDapE whose 
corresponding residue in the mono-zinc substituted HiDapE crystal structure (H349) has been implicated in 
orientating L,L-NSDAP within the active site9. The half maximal value of the descending limb of the pH profile 
Figure 3. Characterization of L,L-NSDAP and L,L-NGDAP synthesised using CgmesoDAP dehydrogenase, 
EcArgD and EcDapD. (a) The electrospray negative ion mass spectrum of L,L-NSDAP. Expected 
[M-H] = 289.1036. (b) The electrospray negative ion mass spectra of L,L-NGDAP. Expected [M-H] = 303.1192. 
(c) Cellulose TLC assessment of purity of L,L-NGDAP (Lane 1) and L,L-NSDAP (Lane 2). The samples were 
spotted and developed in methanol: water: concentrated hydrochloric acid: pyridine (90: 7.5: 2.5: 10), and 
detected by ninhydrin staining.
www.nature.com/scientificreports/
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for MtDapE was 8.2 (Supplementary Fig. S3b). This could relate to dissociation of MtDapE amino acids or the free 
amino group of L,L-NSDAP or both12.
In order to probe the substrate structure-activity relationship of MtDapE, we sought to synthesise and test 
other acyl-L,L-DAP species. In this regard, MtDapE utilised L,L-NG-DAP as a substrate. We established that the 
assay utilising L,L-NG-DAP was linearly dependent on MtDapE protein (Fig. 4c) and found MtDapE to have a Km 
for L,L-NGDAP of 1024 ± 645μM and a kcat of 5.60 ± 2.88 s−1 where the kcat/Km ratio was 0.00547μM.s (Fig. 4d). 
The imprecision of these constants relates to the very high Km for L,L-NGDAP. Nevertheless on comparison of 
kcat/Km ratios, L,L-NGDAP was 28.5-fold less efficient as a substrate than L,L-NSDAP.
Hlaváček et al.23 reported that L,L-NGDAP did not interact with HiDapE. The disparity between our data and 
this observation may be a species discrepancy in DapE specificity. However, Hlaváčeket al.23 employed a DapE 
assay that followed the loss of absorbance due to hydrolysis of L,L-NSDAP (ε 225 nm = 698 M−1.cm−1), a procedure 
that is one ninth as sensitive as the NADPH-coupled assay (ε 340 nm = 6220 M−1.cm−1) employed here.
Response of MtDapE to inhibitors. The assay we developed using our in situ substrate synthesis would 
be of utility for detection of DapE inhibitors which could potentially have antimicrobial properties. Thiols such 
as L-captopril are potent inhibitors of HiDapE14 and NmDapE10 (Ki values 2.8 μM and 1.8 μM respectively). This 
potency stems partly from co-ordination of the L-captopril thiol between the two zinc atoms in the DapE active 
site10. Therefore to extend these studies to MtDapE, we pre-incubated L-captopril and the HiDapE thiol-inhibitors 
L-penicillamine14 and 2-thiopheneboronic acid14 with MtDapE and 31 μM of NS-DAP (the Km for this substrate) 
to determine the impact of these inhibitors on MtDapE.
L-Captopril at 10, 3, and 1 mM exerted 99.96%, 26.67% and 23.34% inhibition of MtDapE activity. This inhi-
bition was considerably less than observed for HiDapE14 and NmDapE10. 1 mM L-penicillamine exerted 79.41% 
inhibition of MtDapE which assuming the competitive kinetics displayed by HiDapE14, suggested that the 
MtDapE Ki for this compound would be 28.2 fold greater than that of the HiDapE14. 2 thiopheneboronic acid was 
similarly far less potent an inhibitor of MtDapE (22.3% at 10 mM) than of the HiDapE14. Assuming this inhibitor 
behaved towards MtDapE in a non-competitive manner as it did towards HiDapE14, this degree of inhibition 
suggested MtDapE would be 515-fold less sensitive to 2-thiopheneboronic acid than HiDapE14.
The unreactivity of inhibitors such as L-captopril towards MtDapE was surprising. We could only detect a sin-
gle zinc ion in the active site of MtDapE. The structure of the L-captopril-inhibited Neisseria enzyme revealed the 
Figure 4. Time course and dependence of catalysis of L,L N-acyl DAP hydrolysis on MtDapE and L,L 
N-acyl DAP concentration. All data points are means of duplicates that differ by no more than 10%. (a) Time 
course of L,L-NSDAP hydrolysis by MtDapE. Conditions as in the text except the [L,L-NSDAP] was 0.16 mM.. 
MtDapE activity was initiated at 1 minute by addition of substrate; (b) Dependence of initial velocity of L,L-
NSDAP hydrolysis on MtDapE concentration. L,L-NSDAP was at 31 μM; (c) Dependence of initial velocity of 
L,L-NGDAP hydrolysis on MtDapE concentration. L,L-NGDAP was at 72.46 μM; (d) Dependence of initial 
velocity of MtDapE-catalysed L,L-N-acyl-DAP hydrolysis on L,L-N-acyl-DAP concentration. For assays in the 
presence of L,L-NSDAP and L,L-NGDAP, MtDapE was at 0.134 μM and 1.05 μM respectively. Data were fitted 
to the Michaelis Menten equation by non-linear regression with GraphPad™ Prizm 4.0.
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thiol of the inhibitor is sandwiched between two zinc ions10 although the loss of one zinc ion does not modify the 
sensitivity of Salmonella enterica DapE to L-captopril15. It was therefore unlikely that the MtDapE was rendered 
insensitive to L-captopril due to the presence of a single zinc within the active site.
On inspection of the crystal structure of the L-captopril complex with NmDapE10, N346, G325, Y198 and 
R179 interact with L-captopril. Sequence alignments (ClustalΩ26, Supplementary Fig. S4) of the MtDapE with 
other DapE homologues reveal that these residues are only completely conserved amongst Gram negative organ-
isms. In contrast, actinomycetes including the mycobacteria have substituted NmDapE residues N346, G325, 
Y198 and R179 with aspartate, tryptophan, arginine and cysteine respectively (Supplementary Fig. S4). These 
substitutions probably underpin the loss of L-captopril potency towards MtDapE10.
The insensitivity of mycobacterial DapE to L-captopril and other DapE inhibitors underscore the requirement 
for the development of novel anti-tubercular drugs. Here, we developed a cheap and efficient method to access 
the L,L-NSDAP substrate of Mt-DapE that may support future screening for new DapE-directed antimicrobials.
Methods
Chemicals, strains and constructs. All the plasmids used in this study are listed in Supplementary 
Table S1. Restriction endonuclease and other enzymes used for cloning were from New England Biolabs (NEB). 
Complete EDTA-free protease inhibitor cocktail tablets were from Roche Diagnostics, Germany. Oligonucleotides 
were from MWG Biotech, Germany. Succinyl-CoA was prepared as in27. meso-DAP was purified according to28. 
NADP+ was from Melford, U.K. All other chemicals used in this study were purchased from Sigma Aldrich. 
Cellulose TLC plates were from Merck, Darmstadt, Germany.
E. coli BL21 (DE3) (Novagen) and C41 (DE3)29 was used for expression. The construct of N-terminal 
His-tagged EcDapD in pFO430 was used in this study. Expression constructs of Corynebacterium glutamicum 
meso-DAP dehydrogenase (Cgmeso-DAP dehydrogenase) in pET28b31 and Bacillus anthracis DapF (BaDapF) in 
pET23a32 were kind gifts from Dr. David Roper, University of Warwick, Coventry, U.K.
Construction of MtdapE and EcargD in pET28b. The MtdapE gene (Rv1202) and E. coli argD33, (an ort-
hologue of dapC in E. coli which functions as a N-Succinyl-L,L-DAP aminotransferase) were amplified from M. 
tuberculosis H37Rv genomic DNA and E. coli MG 1655 genomic DNA respectively by polymerase chain reaction 
with Phusion high fidelity DNA polymerase using the primers in Supplementary Table S1. MtdapE and EcargD 
PCR products were digested with Nde I and Hind III, ligated into similarly digested pET28b vector and trans-
formed into E. coli Top10 competent cells. Plasmid DNA was isolated from overnight Luria Bertani (LB) cultures 
of single transformants grown in the presence of 25 μg/ml kanamycin. The nucleotide sequence of both constructs 
in frame with a 5′ sequence encoding a (His)6 were confirmed by sequencing.
Over expression of (His)6 tagged recombinant proteins. The expression constructs pET28b-MtDapE 
and pET28b-EcArgD encoding MtDapE and EcArgD were transformed into E. coli C41 (DE3). A single 
transformant was inoculated into a starter culture of LB broth containing 25 μg/ml kanamycin and grown 
overnight at 37°C. A 1% (v/v) inoculum of the starter culture was added per litre of terrific broth (MtDapE) 
or LB (EcArgD) and cultures were grown in the presence of 25 μg/ml kanamycin at 37⁰C until an A600 of 0.6 
was reached. The cultures were then cooled to 16 °C and protein expression was induced with 1 mM isopropyl 
β -D-1-thiogalactopyranoside (IPTG) and incubation was continued at 16 °C for 20 hours. The cultures were har-
vested and cell pellets were stored at − 80 °C.
pFO4-EcDapD showed maximal expression of E. coli DapD in BL21 (DE3) cells when induced with 1 mM 
IPTG at 16 °C for 20 hours. The pET23a-BaDapF and pET28b-Cgmeso-DAP dehydrogenase constructs were 
transformed into E coli BL21 (DE3) cells and showed maximum expression of Cgmeso-DAP dehydrogenase and 
BaDapF when grown for 4 to 5 hours at 37 °C after induction with 1 mM IPTG. Five one litre cultures of BaDapF 
and two one litre cultures of Cgmeso-DAP dehydrogenase and EcDapD were grown to obtain sufficient quantities 
of protein after purification.
Purification of (His)6 tagged recombinant proteins. The cell pellets of MtDapE were resuspended 
in Buffer A (25 mM N-(2-hydroxyethyl) piperazine-N′ -(2-ethanesulphonic acid) (HEPES) pH 7.5, 10% (v/v) 
glycerol, 50 mM imidazole and 1 mM dithiothreitol (DTT)) supplemented with complete EDTA-free protease 
inhibitor cocktail and were lysed by sonication at 4 °C with eight 30 seconds pulses interspersed by cooling for 
30 seconds. The insoluble pellet was removed by centrifugation at 4 °C and 27,000 × g for 45 minutes. The soluble 
fraction was purified using a Ni2+-loaded HisTrap high performance affinity column (GE Healthcare) which was 
pre-equilibrated and washed with Buffer A minus the protease inhibitor and eluted isocratically with Buffer A 
containing 200 mM and then 400 mM imidazole. The purity of the protein was assessed by SDS-PAGE. Fractions 
containing MtDapE were pooled and dialysed thrice at 4 °C against 2 litres of buffer B (25 mM HEPES pH 7.5, 
50% (v/v) glycerol and 1 mM DTT) and the protein was stored in − 80 °C.
The same purification protocol was followed for EcArgD and EcDapD except that Buffer A was replaced with 
Buffer C (20 mM Tris.HCl pH 8.0, 0.5 M NaCl, 10% (v/v) glycerol and 1 mM DTT) and the proteins were eluted 
with a gradient of 5–500 mM imidazole in Buffer C. Fractions were analysed by 10% SDS-PAGE and the pure pro-
teins were pooled and dialysed three times against 2 litres of Buffer D (20 mM Tris.HCl pH 8.0, 10% (v/v) glycerol 
and 1 mM DTT). The EcArgD and EcDapD proteins were then concentrated and stored at − 80 °C.
BaDapF was purified essentially as described for MtDapE except that Buffer E (50 mM sodium phosphate 
pH 8.0, 300 mM NaCl, 5 mM imidazole and 1 mM DTT) replaced Buffer A. The column was washed with Buffer 
E containing 10 mM imidazole followed by buffer E containing 50 mM imidazole and then 250 mM imidazole. 
The fractions were dialysed against Buffer F (20 mM Tris.HCl pH 8.0, 150 mM NaCl, 5 mM DTT and 50% (v/v) 
glycerol).
www.nature.com/scientificreports/
8Scientific RepoRts | 6:23191 | DOI: 10.1038/srep23191
Cgmeso-DAP dehydrogenase was purified using a HiTrap Q-Sepharose fast flow anion exchange column (GE 
Healthcare) which was equilibrated and washed with Buffer G (20 mM Tris.HCl pH 8.0 and 1 mM DTT) and 
eluted isocratically with steps of 350, 400, 450, 500 and 1M NaCl in Buffer G. Fractions containing Cgmeso-DAP 
dehydrogenase on SDS PAGE were pooled and dialysed against Buffer H containing 20 mM Tris.HCl pH 8.0, 50% 
(v/v) glycerol and 1 mM DTT and stored at − 80 °C.
Preparation of metal free-MtDapE and inductively coupled plasma optical emission spectros-
copy (ICP-OES) analysis. Metal free MtDapE was prepared by extensive dialysis for three days at 4 °C in 
Chelex 100-treated 20 mM Tricine buffer pH 8.0 containing 10 mM EDTA and 10 mM 1,10 phenanthroline fol-
lowed by Chelex 100-treated 20 mM Tricine buffer pH 8.0. The metal content and the metal to protein ratio of 
MtDapE samples were determined by ICP-OES (Optima 5300 DV, PerkinElmer). Operating conditions were: 
Air flow rate 13.0 L/min, auxiliary gas flow rate 0.2 L/min, nebuliser flow rate 0.8 L/min and RF power at 1300W. 
Sulphur (S) and zinc (Zn) contents of the protein were analysed at 180.669 and 181.975 nm for S and 206.200 and 
213.857 nm for Zn. MtDapE samples were diluted into 0.1 M ultrapure HNO3 and analysed in triplicate, with a 
washing time of 60 seconds for each sample. Data were analysed using WinLab 32 software (PerkinElmer). The 
zinc content of the purified MtDapE was calculated by comparison with solutions of known zinc concentrations.
In situ synthesis of L,L-NSDAP and other DAP derivatives. Two 2 mL reactions were set up: Reaction 
Condition 1 (Schematic in Fig. 1a) contained 20 mM Tricine buffer pH 8.0, 10 mM MgCl2, 8 mM meso-DAP, 
10 mM NADP+, 10 mM succinyl CoA, 4.26 μM Cgmeso-DAP dehydrogenase, 8.03 μM EcDapD, 10 mM 
L-glutamate, 8.97 μM EcArgD, 2 mM pyridoxal phosphate (PLP) and 20 mM DTT. Condition 2, was identical to 
condition 1, except that the NADP+ concentration was reduced to 0.1 mM and in addition contained 950 μg of 
L-glutamate dehydrogenase from Proteus species (Sigma Aldrich) and 36.5 mM of ammonium acetate pH 7.6.
The Reaction condition 2 was also used to attempt the synthesis of N-glutaryl-L,L-DAP (NGDAP), 
N-acetyl-L,L-DAP, N-acetoacetyl-L,L-DAP, N-butyryl-L,L-DAP, N-malonyl-L,L-DAP and N-propionyl-L,L-DAP 
except that the respective CoA substrates used in the reaction were at 1.25 mM. The reactions were incubated at 
37 °C overnight and proteins were removed by centrifugal ultrafiltration through a 10,000 Da cut-off membrane. 
The ultrafiltrates were separated by anion exchange chromatography using a 40 mL Q Sepharose Source 30Q 
column (Amersham Biosciences), which was equilibrated with 10 mM ammonium acetate pH 7.6. The samples 
were diluted 20 fold to 40 ml with 10 mM ammonium acetate pH 7.6 and loaded onto the column, washed with 
five column volumes of 10 mM ammonium acetate pH 7.6 and eluted with fifteen column volumes of an increas-
ing gradient of 10 to 1000 mM ammonium acetate buffer pH 7.6 at a flow rate of 10 ml/min. Chromatography 
was followed at 215 nm and fractions were also screened for their respective DAP derivatives by enzymatic assay 
(below), pooled and lyophilized three times to remove ammonium acetate.
Electrospray mass spectrometry (ES-MS) and thin layer chromatography (TLC) analysis of 
L,L-N-acyl-DAP species. Verification of the identity and masses of L,L-NSDAP and its acyl analogues were 
sought by negative ion mode ES-MS of a 5 μM sample of either substrate in 50% (v/v) acetonitrile using a Waters 
G2 Q-TOF mass spectrometer, calibrated with sodium iodide and operating at a capillary voltage of 1.5 kV. The 
purity of L,L-NSDAP and L,L-NGDAP was determined by TLC on cellulose plates developed in methanol:water:-
concentrated hydrochloric acid:pyridine (90:7.5:2.5:10)34, sprayed with 1% (w/v) ninhydrin in ethanol and heated 
in an oven for a few minutes to develop the purple staining of ninhydrin positive species.
MtDapE coupled assay. The purified L,L-NSDAP and derivatives thereof were tested as a substrate in an 
enzyme assay for MtDapE coupled to DapF. The activity of MtDapE enzyme was measured at 37 °C by following 
the production of NADPH at 340 nm. Unless indicated otherwise, the standard assay consisted of 20 mM Tricine 
pH 8.0, 10 mM MgCl2, 0.6 mM NADP+, 31 μM L,L-NSDAP, 1.99 μM Cgmeso-DAP dehydrogenase, 22.8 μM 
BaDapF and 0.134 μM MtDapE in a total reaction volume of 200 μl. The reaction was initiated by L,L-NSDAP 
after a 60 to 90 second preincubation of other reaction components and was monitored for 10 minutes. Initial 
rates were converted to MtDapE activity (min−1) assuming a molar extinction coefficient of NADPH of 6220 M−1.
cm−1 at 340 nm.
For characterization of the kinetics of MtDapE substrate utilization, initial rates of MtDapE catalysis were 
obtained between 10 μM and 320 μM acyl DAP substrate. Km and kcat values were extracted from fitting initial rate 
data to the Michaelis Menten equation with Graphpad prism 5 by non-linear regression. Further characterisation 
of the temperature and pH optima of the MtDapE enzyme were carried out with the substrate L,L-NSDAP. To 
determine the optimum assay temperature for activity the reaction at pH 8.0 was carried out at 25 °C, 30 °C, 37 °C, 
42 °C, 45 °C and 50 °C. The impact of pH on activity was examined at 37 °C in the pH range 6.0 to 9.0 with 0.5 
unit pH increments at the Km of L,L-NSDAP where the following buffers at 20 mM were used - Sodium acetate 
(pH 5.5), 2-(N-morpholinoethanesulphonic acid (MES) (pH 6), piperazine-N,N′ -bis (2-ethanesulphonic acid) 
(PIPES) (pH 6.5), 3-(N-morpholino) propanesulphonic acid (MOPS) (pH 7), HEPES (pH 7.5), Tricine (pH 8) 
and Tris (hydroxymethyl) aminomethane (Tris.HCl) (pH 8.5 and 9).
EcDapD coupled assay. EcDapD activity was assayed at 37 °C by generating its L-THDP substrate in situ 
and following the production of CoA by its cleavage of dithiobis(2-nitrobenzoate) to para-thionitrobenzoate 
at 412 nm21. The standard assay consisted of 20 mM Tricine pH 8.0, 10 mM MgCl2, 0.3 mM NADP+, 0.1 mM 
5,5′ dithiobis(2-nitrobenzoate), 0.1 mM acyl-Coenzyme A, 0.2 mM meso-DAP, 1.99 μM Cgmeso-DAP dehydro-
genase and 10.03 μM EcDapD in a total reaction volume of 200 μl. The reaction was initiated by the addition of 
EcDapD and continuously monitored. Control assays were performed without meso-DAP to take non-enzymatic 
acyl-CoA hydrolysis into account. Initial rates were converted to EcDapD activity (min−1) assuming a molar 
extinction coefficient of para-thionitrobenzoate of 13,600 M−1.cm−1 at 412 nm.
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